European Biological Variation Study (EuBIVAS): within- and between-subject biological variation estimates of β-isomerized C-terminal telopeptide of type I collagen (β-CTX), N-terminal propeptide of type I collagen (PINP), osteocalcin, intact fibroblast growth factor 23 and uncarboxylated-unphosphorylated matrix-Gla protein—a cooperation between the EFLM Working Group on Biological Variation and the International Osteoporosis Foundation-International Federation of Clinical Chemistry Committee on Bone Metabolism

E. Cavalier, P. Lukas, M. Bottani, A.K. Aarsand, F. Ceriotti, A. Coşkun, J. Díaz-Garzón, P. Fernàndez-Calle, E. Guerra, M. Locatelli, S. Sandberg, A. Carobene, K. Åkesson, H.P. Bhattoa, O. Bruyère, C. Cooper, R. Eastell, P. Garnero, A. Heijboer, N.R. JorgensenJ. Kanis, K. Makris, C.Z. Ulmer, S. Vasikaran, on behalf of the European Federation of Clinical Chemistry and Laboratory Medicine Working Group on Biological Variation and IOF-IFCC Committee on Bone Metabolism

Research output: Contribution to journalArticlepeer-review

Cite this